Filter Results:
(134)
Show Results For
- All HBS Web
(219)
- News (49)
- Research (134)
- Events (1)
- Multimedia (1)
- Faculty Publications (68)
Show Results For
- All HBS Web
(219)
- News (49)
- Research (134)
- Events (1)
- Multimedia (1)
- Faculty Publications (68)
Sort by
- August 2019 (Revised February 2020)
- Case
New Hope Liuhe: Building an Integrated Agri-Food Business
By: Forest L. Reinhardt, Shu Lin, Natalie Kindred and Nancy Hua Dai
In October 2018, LIU Chang (Angela), chairman of Beijing-based New Hope Liuhe (NHL), was considering the strategy of the firm. With $9 billion in sales and a presence in nearly 20 countries, NHL was China’s largest animal feed producer and a major pork and poultry... View Details
Keywords: Strategy; Corporate Strategy; Food; Agribusiness; Expansion; Diversification; Growth Management; Consumer Behavior; Change Management; Entrepreneurship; Organizational Structure; Organizational Change and Adaptation; Government and Politics; Animal-Based Agribusiness; Transformation; Volatility; Business Cycles; Goods and Commodities; Supply Chain; Product; Food and Beverage Industry; Food and Beverage Industry; China; Asia
Reinhardt, Forest L., Shu Lin, Natalie Kindred, and Nancy Hua Dai. "New Hope Liuhe: Building an Integrated Agri-Food Business." Harvard Business School Case 720-009, August 2019. (Revised February 2020.)
- August 2008 (Revised September 2008)
- Case
The Flaxil Label (A)
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Product Launch; Negotiation Process; Business and Government Relations; Safety; Pharmaceutical Industry
Barron, Greg M. "The Flaxil Label (A)." Harvard Business School Case 909-001, August 2008. (Revised September 2008.)
- August 2008 (Revised September 2008)
- Case
The Flaxil Label (B)
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States
Barron, Greg M. "The Flaxil Label (B)." Harvard Business School Case 909-002, August 2008. (Revised September 2008.)
- 28 Mar 2023
- Research & Ideas
The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation
Early in the COVID-19 pandemic, the US Food and Drug Administration faced the task of convincing a skeptical public of the safety of new vaccines when the agency began authorizing them for emergency use less... View Details
- September 1991 (Revised August 1994)
- Background Note
Note on Pharmaceutical Industry Regulation
Traces the evolution of U.S. regulatory policy towards the pharmaceutical industry over the course of the twentieth century. A major theme is the steady shift away from a policy of 'let the buyer beware' to the creation of a complex and time-consuming review process,... View Details
Keywords: Safety; Industry Growth; Marketing; Research and Development; Health Testing and Trials; Economics; Pharmaceutical Industry; United States
Emmons, Willis M., III. "Note on Pharmaceutical Industry Regulation." Harvard Business School Background Note 792-002, September 1991. (Revised August 1994.)
- 27 Nov 2006
- Research & Ideas
Manly Men, Oil Platforms, and Breaking Stereotypes
interview, Ely discusses the origins of the research, her experiences aboard an oil platform, and how this research can improve safety at other job sites. Sarah Jane Gilbert: How do you define masculine identity and what led you to study... View Details
- 2018
- Book
Rebel Talent: Why It Pays to Break the Rules at Work and Life
By: F. Gino
The world’s best chef.
An airline captain who brought his flight to safety in a daring water landing.
A magician known for his sensational escape acts.
A computer scientist who founded a world-renowned animation studio.
What do all of these... View Details
An airline captain who brought his flight to safety in a daring water landing.
A magician known for his sensational escape acts.
A computer scientist who founded a world-renowned animation studio.
What do all of these... View Details
Gino, F. Rebel Talent: Why It Pays to Break the Rules at Work and Life. New York: Dey Street Books, 2018.
- 2020
- Book
Think Outside the Building: How Advanced Leaders Can Change the World One Smart Innovation at a Time
Over a decade ago, renowned innovation expert Rosabeth Moss Kanter co-founded and then directed Harvard’s Advanced Leadership Initiative. Her breakthrough work with hundreds of successful professionals and executives, as well as aspiring young entrepreneurs, identifies... View Details
Keywords: Leaders; Advanced Leadership; Advanced Leadership Initiative; Community; Change Leadership; Innovation; Problem Solving; Cross-sector Collaboration; Institutional Change; Leadership; Change; Leading Change; Communication; Innovation Leadership; Collaborative Innovation and Invention; Organizational Change and Adaptation; Business and Community Relations; Civil Society or Community
Kanter, Rosabeth Moss. Think Outside the Building: How Advanced Leaders Can Change the World One Smart Innovation at a Time. New York: PublicAffairs, 2020.
- December 2016 (Revised March 2017)
- Case
Beingmate
By: David E. Bell, Juan Ma and Natalie Kindred
Founded in 2002, Hangzhou, China–based Beingmate was a major producer of infant formula and related products in the high-demand Chinese market. After an infamous 2008 food safety episode in China, in which toxic infant formula sickened thousands of babies and led to... View Details
Keywords: Marketing Strategy; Competitive Strategy; Partners and Partnerships; Food and Beverage Industry; China
Bell, David E., Juan Ma, and Natalie Kindred. "Beingmate." Harvard Business School Case 517-050, December 2016. (Revised March 2017.)
- 2010
- Chapter
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
By: Arthur A. Daemmrich
Adverse drug reactions pose distinct but potentially catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Business and Government Relations; Risk and Uncertainty; Safety; Pharmaceutical Industry; United States
Daemmrich, Arthur A. "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance." Chap. 13 in The Fragmentation of U.S. Health Care: Causes and Solutions, edited by Einer Elhauge, 301–322. Oxford: Oxford University Press, 2010.
- 10 Feb 2009
- First Look
First Look: February 10, 2009
b01/en/common/item_detail.jhtml?id=809095 GLOBALGAP: Food Safety and Private Standards Harvard Business School Case 509-004 In response to new laws governing liability and several View Details
Keywords: Martha Lagace
- November 2017
- Case
The 'Wonder Drug' That Killed Babies
By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Public Administration Industry; United States; United Kingdom; Australia; Germany; Europe
Krieger, Joshua Lev, Tom Nicholas, and Matthew Preble. "The 'Wonder Drug' That Killed Babies." Harvard Business School Case 818-044, November 2017.
- 21 Jun 2011
- First Look
First Look: June 21
refrigerated food products, primarily poultry, it begins by describing broad patterns about the use of alternative financing terms. These patterns help discipline a model in which the trade finance mode is shaped by the risk that an... View Details
Keywords: Sean Silverthorne
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- 07 Oct 2014
- First Look
First Look: October 7
comparative advantages of intermediate versus final disclosure policies in fostering innovation. Publisher's link: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2288746 October 2014 The Compass (Newsletter of the American Society of View Details
Keywords: Sean Silverthorne
- April 2020
- Article
Regulatory Oversight, Causal Inference, and Safe and Effective Health Care Machine Learning
By: Ariel Dora Stern and W. Nicholson Price, II
In recent years, the applications of Machine Learning (ML) in the health care delivery setting have grown to become both abundant and compelling. Regulators have taken notice of these developments and the U.S. Food and Drug Administration (FDA) has been engaging... View Details
Keywords: Machine Learning; Causal Inference; Health Care and Treatment; Safety; Governing Rules, Regulations, and Reforms
Stern, Ariel Dora, and W. Nicholson Price, II. "Regulatory Oversight, Causal Inference, and Safe and Effective Health Care Machine Learning." Biostatistics 21, no. 2 (April 2020): 363–367.
- August 2009 (Revised August 2009)
- Case
Swire Beverages: Implementing CSR in China
By: Christopher Marquis, G.A. Donovan and YiKwan Chu
Swire Beverage, the largest Coca-Cola bottler in China, recently created a corporate social responsibility (CSR) organization to oversee environmental, community, health and safety initiatives at the companies' nine bottling plants in China. The case considers... View Details
Keywords: Brands and Branding; Corporate Social Responsibility and Impact; Organizational Design; Business and Stakeholder Relations; Partners and Partnerships; Non-Governmental Organizations; Food and Beverage Industry; China
Marquis, Christopher, G.A. Donovan, and YiKwan Chu. "Swire Beverages: Implementing CSR in China." Harvard Business School Case 410-021, August 2009. (Revised August 2009.)
- 20 Nov 2012
- First Look
First Look: November 20
lifestyle and food choices of its employees or customers. But Boyan and his team thought differently. Purchase this case:http://hbr.org/search/512034-PDF-ENG The Product Manager Jeffrey Bussgang, Thomas Eisenmann, and Robert GoHarvard... View Details
Keywords: Sean Silverthorne
- November 2020
- Case
Truebird—An AlleyCorp Venture
By: Shikhar Ghosh and Shweta Bagai
In December 2018, Kevin Ryan and Wendy Tsu faced an important decision – to finalize the CEO candidate for Truebird, an innovative, automated coffee café concept. Like many of AlleyCorp and Ryan’s companies, Truebird started with the observation of an unmet need – an... View Details
Keywords: Startup; Hiring; Staffing; Recruiting; Business Startups; Finance; Leadership; Management Skills; Management Teams; Jobs and Positions; Job Interviews; Human Resources; Recruitment; Selection and Staffing; Food and Beverage Industry; Food and Beverage Industry; United States
Ghosh, Shikhar, and Shweta Bagai. "Truebird—An AlleyCorp Venture." Harvard Business School Case 821-030, November 2020.
- 15 Nov 2011
- First Look
First Look: November 15
The company could also revisit the previous two applications, tracking and tracing processed meat and tracking employee safety practices. At the other extreme, after seven years of R&D and marketing efforts and millions of dollars in... View Details
Keywords: Sean Silverthorne